We are live on
!
Find out more
LWM
Laidlaw Wealth Management Portfolio holdings
AUM
$28.8M
1-Year Est. Return
37.7%
This Fund
S&P 500
This Quarter
Est. Return
+18.91%
1 Year Est. Return
+37.7%
3 Year Est. Return
+116.32%
5 Year Est. Return
+137.52%
10 Year Est. Return
–
AUM
$192M
AUM Growth
+$38.8M
(+25%)
Cap. Flow
+$13M
Cap. Flow
% of AUM
6.78%
Top 10 Holdings %
Top 10 Hldgs %
29.14%
Holding
187
New
37
Increased
97
Reduced
46
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
+$1.62M |
| 2 |
HQH
abrdn Healthcare Investors
HQH
|
+$859K |
| 3 |
ASPU
ASPEN GROUP, INC.
ASPU
|
+$459K |
| 4 |
Amazon
AMZN
|
+$432K |
| 5 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$424K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.14M |
| 2 |
SPDR Gold Trust
GLD
|
+$591K |
| 3 |
Gilead Sciences
GILD
|
+$261K |
| 4 |
ClearShares Ultra-Short Maturity ETF
OPER
|
+$227K |
| 5 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$219K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.36% |
| 2 | Healthcare | 7.64% |
| 3 | Communication Services | 7.37% |
| 4 | Consumer Staples | 6.14% |
| 5 | Consumer Discretionary | 5.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRIL
176
DELISTED
Trillium Therapeutics Inc.
TRIL
| $85K | 0.04% |
+10,500
| New | +$65K |
|
177
Verastem
VSTM
$610M
| $82K | 0.04% |
+3,983
| New | +$105K |
|
178
Invesco Mortgage Capital
IVR
$805M
| $75K | 0.04% |
1,998
+168
| +9% | +$5.78K |
|
179
GE Aerospace
GE
$384B
| $74K | 0.04% |
+2,181
| New | +$73.5K |
|
|
CHMA
180
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $54K | 0.03% |
+10,000
| New | +$55.1K |
|
|
IMMP
181
Immutep
IMMP
$56.9M
| $15K | 0.01% |
+13,800
| New | +$14.2K |
|
182
Actinium Pharmaceuticals
ATNM
$25M
| $10K | 0.01% |
+933
| New | +$7.07K |
|
|
ACB
183
Aurora Cannabis
ACB
$185M
| – | – |
-120
| Closed | -$13K |
|
184
Akebia Therapeutics
AKBA
$252M
| – | – |
-10,195
| Closed | -$77K |
|
185
Alerian MLP ETF
AMLP
$12.8B
| – | – |
-2,489
| Closed | -$43K |
|
|
186
Gilead Sciences
GILD
$165B
| – | – |
-3,490
| Closed | -$261K |
|
|
187
Invesco QQQ Trust
QQQ
$484B
| – | – |
-6,004
| Closed | -$1.14M |
|
Similar funds
CPM
PL
AC
TCM
LGM
AIIC
LTM
BWG
Laidlaw Wealth Management's Q2 2020 Portfolio in Review
As of Q2 2020, Laidlaw Wealth Management held 187 positions worth $192M, up 25% from $153M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Laidlaw Wealth Management deployed $13M of net new capital in Q2 2020, opening 37 new positions and adding to 97 existing holdings. Its largest new stake was Goldman Sachs Access Treasury 0-1 Year ETF: 16,115 shares worth $1.62M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was SPDR Gold Trust, an estimated $591K trimmed.
- Laidlaw Wealth Management's largest Q2 2020 buy was Goldman Sachs Access Treasury 0-1 Year ETF: 16,115 shares worth $1.62M.
- Laidlaw Wealth Management added most to abrdn Healthcare Investors in Q2 2020, an estimated $859K increase.
- Laidlaw Wealth Management's biggest Q2 2020 reduction was SPDR Gold Trust, cutting an estimated $591K.
- Laidlaw Wealth Management fully exited Invesco QQQ Trust in Q2 2020, selling an estimated $1.14M.
- Laidlaw Wealth Management's ten largest holdings make up 29% of its $192M portfolio in Q2 2020.
- Laidlaw Wealth Management opened 37 new positions and closed 5 in Q2 2020.
- Laidlaw Wealth Management's portfolio value rose 25% quarter-over-quarter to $192M.
Based on Laidlaw Wealth Management's 13F filing for Q2 2020, filed 13 Aug 2020.